Mantle Cell Lymphoma  >>  itacitinib (INCB039110)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
itacitinib (INCB039110) / Incyte
GRAVITAS-119, NCT03320642: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Terminated
1
84
Europe, US
Itacitinib, INCB039110, Calcineurin inhibitor
Incyte Corporation
Hematologic Malignancies
02/21
02/22
NCT01905813: Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Active, not recruiting
1
121
US
INCB040093, INCB040093 + itacitinib, itacitinib (INCB039110)
Incyte Corporation
B-cell Malignancies
08/24
08/24

Download Options